ABOUT US
About Us
A full-dosage-form penicillin manufacturer integrating R&D, production, sales and service
Zhongshan Lean&Leap Pharmaceutical Co., Ltd.
Founded in 2015 with a registered capital of RMB 50 million, Zhongshan Lean&Leap Pharmaceutical Co., Ltd. is a wholly-owned pharmaceutical manufacturer of Guangdong Lean&Leap Pharmaceutical Investment Holdings Co., Ltd., formerly the Yongning penicillin formulation plant of Kangtian Pharmaceutical (Zhongshan) Co., Ltd.
The company operates both oral and injectable penicillin workshops, with China's most complete penicillin production lines — tablets, capsules, granules, dry suspensions and powder-for-injection — and was certified under the new GMP standard in 2015.
As a Zhongshan Engineering Research Center, an above-designated-size industrial enterprise and a Guangdong Innovative SME, Lean&Leap has been recognized as a National High-tech Enterprise and a Specialized, Refined, Distinctive & Innovative (SRDI) enterprise for consecutive years, and received the 'Scale Leap Award' from the Xiaolan Town People's Government. With over RMB 100 million invested in R&D, 5 invention patents and 8 software copyrights, our products reach the domestic market and more than 20 countries across Southeast Asia, the Middle East and beyond.
A culture built on shared values
Lean&Leap attaches great importance to building a value-centered corporate culture — one that integrates enterprise values with personal career development, presents the beliefs, ideas and tenets of Lean&Leap people, and guides their behavior and decision-making.
From a penicillin plant to a full-dosage-form manufacturer
Plant relocation
In September, Lean&Leap began cooperation with Livzon Pharmaceutical and Kangtian Pharmaceutical (Zhongshan).
Equity transfer talks
The penicillin solid-formulation workshop was relocated in its entirety to Kangtian Pharmaceutical (Zhongshan).
New GMP upgrade
Asset handover was completed in February and the company entered spin-off restructuring. The new GMP upgrade began in July; by December, the re-registration transfer of 23 product approvals was completed, the new Drug Manufacturing License and new GMP certificate were granted, and the equity change was finalized.
Full operation
From January 1, Zhongshan Lean&Leap Pharmaceutical Co., Ltd. commenced full production and operation.
Amoxicillin Granules
2022-04-12 · 0.125 g / 0.25 g · Passed generic drug consistency evaluation.
Scale leap
Record-high output value and the 'Scale Leap Award' from the Xiaolan Town People's Government.
Amoxicillin Capsules
2023-08-30 · 0.25 g / 0.5 g · Passed generic drug consistency evaluation.
Amoxicillin & Clavulanate Potassium Tablets
2024-03-29 · 1.0 g · Passed generic drug consistency evaluation.
Ampicillin Sodium and Sulbactam Sodium for Injection
2025-06-03 · 0.75 g / 1.5 g · Passed generic drug consistency evaluation.
Amoxicillin Sodium and Clavulanate Potassium for Injection
2026-01-23 · 0.3 g / 0.6 g / 1.2 g · Passed generic drug consistency evaluation.
Piperacillin Sodium and Tazobactam Sodium for Injection
2026-10-14 · 2.25 g / 4.5 g · Passed generic drug consistency evaluation.
Licenses and approval documents
Organizational Structure
The company operates under a General Manager responsibility system led by the Board, with the Marketing Center, Manufacturing Center, Quality Assurance Department, Laboratories and International Registration Department.
Click a functional center to view its departments and responsibilities
Marketing Center
Discuss cooperation →Oversees domestic distribution, controlled-marketing, B2B/B2C platform supply and export sales, with six departments: Marketing Management, Marketing, Medical Affairs, Commercial Sales, Retail Terminal and Foreign Trade.